New market study, "Philippines Pharmaceuticals & Healthcare Report Q1 2016", has been published

From: Fast Market Research, Inc.
Published: Fri Feb 12 2016

Healthcare access in the Philippine s has improved through the expansion of the country's universal health insurance scheme and the proposed 2016 government budget will aid further expansion. The count r y's growing population, increasing disease burden (particularly cancer and cardiovascular diseases) and rising acceptance of affordable generic drugs, will drive growth in the pharmaceutical market. However, pharmaceutical firms seeking to capture the commercial opportunities from the large unmet medical need in the Philippines's oncology space will face challenges, as undiagnosed cancer cases remain high and many advanced treatments still require out of pocket payment.

Headline Expenditure Projections

Pharmaceuticals: PHP145.05bn (USD3.28bn) in 2014, rising to PHP150.44bn (USD3.27bn) in 2015; +3.7% in local currency terms and -0.3% in US dollar terms. Forecast revised downwards slightly from last quarter .
Healthcare: PHP562.90bn (USD12.74bn) in 2014, rising to PHP622.99bn (USD13.54bn) in 2015; +10.7% in local currency terms and +6.4% in US dollar terms. Revised downwards from last quarter.

Full Report Details at

The Philippines Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Philippines Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Philippines pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Philippines, to test other views - a key input for successful budgeting and strategic business planning in the Philippine pharmaceutical and healthcare market.
* Target business opportunities and risks in the Philippine pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Philippines.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.


BMI Industry View

An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assumptions underpinning BMI’s forecast analysis, and taken together with BMI’s political, economic and business environment SWOTs, it gives a complete overview of market climate.

BMI Industry Forecast Scenario

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- France Pharmaceuticals & Healthcare Report Q1 2016
- Saudi Arabia Pharmaceuticals & Healthcare Report Q1 2016
- Kenya Pharmaceuticals & Healthcare Report Q1 2016
- Ukraine Pharmaceuticals & Healthcare Report Q1 2016
- Thailand Pharmaceuticals & Healthcare Report Q1 2016

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »